Recommendations and Clinical Guidance for Children with Metabolic-associated Fatty Liver Disease during the COVID-19 Pandemic
J Clin Transl Hepatol
.
2021 Feb 28;9(1):1-2.
doi: 10.14218/JCTH.2020.00137.
Epub 2021 Feb 1.
Authors
Yong-Hai Zhou
1
,
Rafael S Rios
2
,
Kenneth I Zheng
2
,
Ming-Hua Zheng
2
3
4
Affiliations
1
Department of Pediatrics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
2
MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
3
Institute of Hepatology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
4
Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, Zhejiang, China.
PMID:
33604249
PMCID:
PMC7868690
DOI:
10.14218/JCTH.2020.00137
No abstract available
Keywords:
COVID-19; Children; MAFLD.
Publication types
Editorial